{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:33:07Z","timestamp":1786984387458,"version":"build-2736575974"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.antiviral.2014.02.012","type":"journal-article","created":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T17:01:36Z","timestamp":1393347696000},"page":"80-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["Treatment of norovirus infections: Moving antivirals from the bench to the bedside"],"prefix":"10.1016","volume":"105","author":[{"given":"Stuart S.","family":"Kaufman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Y.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent E.","family":"Korba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.02.012_b0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.virol.2012.01.016","article-title":"Crystal structures of murine norovirus-1 RNA-dependent RNA polymerase in complex with 2-thiouridine or ribavirin","volume":"426","author":"Alam","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.02.012_b0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000152844","article-title":"Efficacy of partially hydrolyzed guar gum-added oral rehydration solution in the treatment of severe cholera in adults","volume":"78","author":"Alam","year":"2008","journal-title":"Digestion"},{"key":"10.1016\/j.antiviral.2014.02.012_b0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3201\/eid0602.009918","article-title":"Norwalk-like viral gastroenteritis outbreak in U.S. Army trainees","volume":"6","author":"Arness","year":"2000","journal-title":"Emerg. Infect Dis."},{"key":"10.1016\/j.antiviral.2014.02.012_b0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.gtc.2006.03.001","article-title":"The epidemiologic and clinical importance of norovirus infection","volume":"35","author":"Atmar","year":"2006","journal-title":"Gastroenterol. Clin. North Am."},{"key":"10.1016\/j.antiviral.2014.02.012_b0025","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1128\/JVI.79.4.2393-2403.2005","article-title":"Norovirus proteinase-polymerase and polymerase are both active forms of RNA-dependent RNA polymerase","volume":"79","author":"Belliot","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S0950268813000435","article-title":"Epidemiology of norovirus gastroenteritis in Germany 2001\u20132009: eight seasons of routine surveillance","volume":"142","author":"Bernard","year":"2014","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.antiviral.2014.02.012_b0035","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMra1207742","article-title":"Norovirus gastroenteritis in immunocompromised patients","volume":"367","author":"Bok","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.02.012_b0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1073\/pnas.1014577107","article-title":"Chimpanzees as an animal model for human norovirus infection and vaccine development","volume":"108","author":"Bok","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2014.02.012_b0045","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbmt.2010.09.014","article-title":"Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus","volume":"17","author":"Boudreault","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.antiviral.2014.02.012_b0050","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/infdis\/jis206","article-title":"The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States","volume":"205","author":"Bresee","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.02.012_b0055","doi-asserted-by":"crossref","first-page":"8587","DOI":"10.1128\/JVI.00005-09","article-title":"Role of cholesterol pathways in norovirus replication","volume":"83","author":"Chang","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0060","doi-asserted-by":"crossref","first-page":"12111","DOI":"10.1128\/JVI.00560-07","article-title":"Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells","volume":"81","author":"Chang","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0065","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.virol.2006.06.006","article-title":"Stable expression of a Norwalk virus RNA replicon in a human hepatoma cell line","volume":"353","author":"Chang","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.02.012_b0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.virol.2011.12.002","article-title":"Characterization and inhibition of Norovirus proteases of genogroups I and II using a florescence resonance energy transfer assay","volume":"423","author":"Chang","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.02.012_b0075","doi-asserted-by":"crossref","first-page":"10372","DOI":"10.1128\/JVI.00809-06","article-title":"Pathogenesis of a genogroup II human norovirus in gnotobiotic pigs","volume":"80","author":"Cheetham","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0080","doi-asserted-by":"crossref","first-page":"9547","DOI":"10.1128\/JVI.01376-13","article-title":"Development of Norwalk virus-specific monoclonal antibodies with therapeutic potential for the treatment of Norwalk virus gastroenteritis","volume":"87","author":"Chen","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0085","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/095632020501600406","article-title":"Synthesis and anti-rhinovirus properties of fluoro-substituted flavonoids","volume":"16","author":"Conti","year":"2005","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2014.02.012_b0090","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1365-2036.2007.03456.x","article-title":"Epidemiology of slow and fast colonic transit using a scale of stool form in a community","volume":"26","author":"Choung","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2014.02.012_b0095","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3851\/IMP2229","article-title":"Antiviral activity of nucleoside analogues against Norovirus","volume":"17","author":"Costantini","year":"2012","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2014.02.012_b0100","doi-asserted-by":"crossref","unstructured":"De Clercq, E., in press. Dancing with chemical formulae of antivirals: a panoramic view (part 2). Biochem. Pharm. http:\/\/dx.doi.org\/10.1016\/j.bcp.2013.09.010.","DOI":"10.1016\/j.bcp.2013.09.010"},{"key":"10.1016\/j.antiviral.2014.02.012_b0105","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s00415-011-6200-0","article-title":"Challenges of clinical trial design when there is lack of clinical equipoise: use of a response-conditional crossover design","volume":"259","author":"Deng","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0110","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.idc.2013.05.009","article-title":"Epidemiology, prevention, and control of the number one foodborne illness: human norovirus","volume":"27","author":"Dicaprio","year":"2013","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.antiviral.2014.02.012_b0115","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ajic.2012.10.025","article-title":"An outbreak of norovirus infection in a bone marrow transplant unit","volume":"41","author":"Doshi","year":"2013","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.antiviral.2014.02.012_b0120","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1016\/j.bmc.2011.08.032","article-title":"Design and synthesis of inhibitors of noroviruses by scaffold hopping","volume":"19","author":"Dou","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2014.02.012_b0125","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bmcl.2011.10.122","article-title":"Inhibition of noroviruses by piperazine derivatives","volume":"22","author":"Dou","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2014.02.012_b0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmech.2011.10.019","article-title":"Cyclosulfamide-based derivatives as inhibitors of noroviruses","volume":"47","author":"Dou","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.antiviral.2014.02.012_b0135","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.bmc.2012.01.030","article-title":"Potent norovirus inhibitors based on the acyclic sulfamide scaffold","volume":"20","author":"Dou","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2014.02.012_b0140","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10096-013-1967-9","article-title":"Pediatric norovirus infection","volume":"33","author":"Esposito","year":"2014","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.02.012_b0145","doi-asserted-by":"crossref","first-page":"e63269","DOI":"10.1371\/journal.pone.0063269","article-title":"Norovirus P particle efficiently elicits innate, humoral and cellular immunity","volume":"8","author":"Fang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2014.02.012_b0150","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1128\/AAC.00627-06","article-title":"Library screen for inhibitors targeting norovirus binding to histo-blood group antigen receptors","volume":"51","author":"Feng","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.02.012_b0155","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","article-title":"Favipiravir (T-705), a novel viral RNA polymerase inhibitor","volume":"100","author":"Furuta","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2014.02.012_b0160","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1021\/jm900447q","article-title":"Phosphoramidate prodrugs of 2\u2032-C-methylcytidine for therapy of hepatitis C virus infection","volume":"52","author":"Gardelli","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2014.02.012_b0165","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/infdis\/jis942","article-title":"Burden of norovirus gastroenteritis in the ambulatory setting \u2013 United States, 2001\u20132009","volume":"207","author":"Gasta\u00f1aduy","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.02.012_b0170","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.4315\/0362-028X.JFP-13-079","article-title":"Multiple outbreaks of gastroenteritis that were associated with 16 funerals and a unique caterer and spanned 6 days","volume":"76","author":"Gaulin","year":"2011","journal-title":"J. Food Prot."},{"key":"10.1016\/j.antiviral.2014.02.012_b0175","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1056\/NEJMra0804575","article-title":"Norovirus gastroenteritis","volume":"361","author":"Glass","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2014.02.012_b0180","series-title":"Fields Virology","first-page":"582","article-title":"Caliciviridae: the noroviruses","author":"Green","year":"2013"},{"key":"10.1016\/j.antiviral.2014.02.012_b0185","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1017\/S0950268808000757","article-title":"Enteric outbreaks in long-term care facilities and recommendations for prevention: a review","volume":"137","author":"Greig","year":"2009","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.antiviral.2014.02.012_b0190","first-page":"1","article-title":"Updated norovirus outbreak management and disease prevention guidelines","volume":"60","author":"Hall","year":"2011","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.antiviral.2014.02.012_b0195","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3201\/eid1908.130465","article-title":"Norovirus disease in the United States","volume":"19","author":"Hall","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.02.012_b0200","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3201\/eid1908.130482","article-title":"Acute gastroenteritis surveillance through the National Outbreak Reporting System, United States","volume":"19","author":"Hall","year":"2013","journal-title":"Emerg. Infect. Dis."},{"issue":"3","key":"10.1016\/j.antiviral.2014.02.012_b0205","doi-asserted-by":"crossref","first-page":"e003060","DOI":"10.1136\/bmjopen-2013-003060","article-title":"Does spatial proximity drive norovirus transmission during outbreaks in hospitals?","volume":"13","author":"Harris","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.antiviral.2014.02.012_b0210","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/jmv.23552","article-title":"Prevalence and genetic diversity of norovirus infection in Tunisian children (2007\u20132010)","volume":"85","author":"Hassine-Zaafrane","year":"2013","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0215","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/jmv.23734","article-title":"Isolation of cross-reactive human monoclonal antibodies that prevent binding of human noroviruses to histo-blood group antigens","volume":"86","author":"Higo-Moriguchi","year":"2014","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0220","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jcv.2013.08.013","article-title":"Molecular epidemiology of norovirus infections in symptomatic and asymptomatic children from Bobo Dioulasso, Burkina Faso","volume":"58","author":"Huynen","year":"2013","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0225","doi-asserted-by":"crossref","first-page":"e58605","DOI":"10.1371\/journal.pone.0058605","article-title":"Two gastroenteritis outbreaks caused by GII Noroviruses: host susceptibility and HBGA phenotypes","volume":"8","author":"Jin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2014.02.012_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041619","article-title":"The effect of simvastatin or interferon-\u03b1 on infectivity of human Norovirus using a gnotobiotic pig model for the study of antivirals","volume":"7","author":"Jung","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2014.02.012_b0235","series-title":"Fields Virology","first-page":"783","article-title":"Norwalk group of viruses","author":"Kapikian","year":"1997"},{"key":"10.1016\/j.antiviral.2014.02.012_b0240","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/01.MPG.0000155182.54001.48","article-title":"Characteristics of human Calicivirus enteritis in intestinal transplant recipients","volume":"40","author":"Kaufman","year":"2005","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.antiviral.2014.02.012_b0245","doi-asserted-by":"crossref","first-page":"11754","DOI":"10.1128\/JVI.01348-12","article-title":"Broad-spectrum antivirals against 3C or 3C-like proteases of Picornaviruses, Noroviruses, and Coronaviruses","volume":"86","author":"Kim","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0250","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jpids\/pis070","article-title":"Noroviruses: the most common pediatric viral enteric pathogen at a large university hospital after introduction of rotavirus vaccination","volume":"2","author":"Koo","year":"2013","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"issue":"Suppl. 3","key":"10.1016\/j.antiviral.2014.02.012_b0255","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ajt.12006","article-title":"CMV: prevention, diagnosis and therapy","volume":"13","author":"Kotton","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.antiviral.2014.02.012_b0260","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1128\/JCM.00499-08","article-title":"Analysis of integrated virological and epidemiological reports of norovirus outbreaks collected within the Foodborne Viruses in Europe network from 1 July 2001 to 30 June 2006","volume":"46","author":"Kroneman","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0265","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/1471-2334-13-446","article-title":"Incubation periods of viral gastroenteritis: a systematic review","volume":"13","author":"Lee","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.02.012_b0270","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev-food-022811-101234","article-title":"New interventions against human Norovirus; progress, opportunities, and challenges","volume":"3","author":"Li","year":"2012","journal-title":"Annu. Rev. Food Sci. Technol."},{"issue":"5","key":"10.1016\/j.antiviral.2014.02.012_b0275","doi-asserted-by":"crossref","first-page":"e1002705","DOI":"10.1371\/journal.ppat.1002705","article-title":"Immunogenetic mechanisms driving norovirus GII.4 antigenic variation","volume":"8","author":"Lindesmith","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2014.02.012_b0280","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/jmv.21217","article-title":"Quantitative detection of norovirus excretion in pediatric patients with cancer and prolonged gastroenteritis and shedding of norovirus","volume":"80","author":"Ludwig","year":"2008","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0285","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bmcl.2012.11.026","article-title":"Inhibition of norovirus 3CL protease by bisulfite adducts of transition state inhibitors","volume":"23","author":"Mandadapu","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2014.02.012_b0290","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jmb.2012.03.008","article-title":"Structure-based inhibition of Norovirus RNA-dependent RNA polymerases","volume":"419","author":"Mastrangelo","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0295","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1017\/S0950268813000496","article-title":"Heterogeneity in norovirus shedding duration affects community risk","volume":"141","author":"Milbrath","year":"2013","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.antiviral.2014.02.012_b0300","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12560-012-9085-x","article-title":"Rapid detection of norovirus in naturally contaminated food: foodborne gastroenteritis outbreak on a cruise ship in Brazil, 2010","volume":"4","author":"Morillo","year":"2012","journal-title":"Food Environ. Virol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0305","first-page":"1095","article-title":"Norovirus outbreaks on three college campuses \u2013 California, Michigan, and Wisconsin, 2008","volume":"58","author":"MMWR","year":"2009","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.antiviral.2014.02.012_b0310","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.4315\/0362-028X-73.12.2232","article-title":"Comparative efficacy of seven hand sanitizers against murine Norovirus, feline Calicivirus, and GII.4 Norovirus","volume":"12","author":"Park","year":"2010","journal-title":"J. Food Prot."},{"issue":"7","key":"10.1016\/j.antiviral.2014.02.012_b0315","doi-asserted-by":"crossref","first-page":"e1002783","DOI":"10.1371\/journal.ppat.1002783","article-title":"Antiviral activity of a small molecule deubiquitinase inhibitor occurs via induction of the unfolded protein response","volume":"8","author":"Perry","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2014.02.012_b0320","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1021\/jm0603623","article-title":"Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2\u2032-C-methylcytidine","volume":"49","author":"Pierra","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2014.02.012_b0325","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/apt.12163","article-title":"Review article: the management of acute gastroenteritis in children","volume":"37","author":"Pie\u015bcik-Lech","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2014.02.012_b0330","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1016\/j.bmcl.2012.03.084","article-title":"Synthesis and anti-norovirus activity of pyranobenzopyrone compounds","volume":"22","author":"Pokhrel","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2014.02.012_b0335","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1016\/j.bmcl.2013.09.070","article-title":"Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors","volume":"23","author":"Prior","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2014.02.012_b0340","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1128\/AAC.06283-11","article-title":"Pharmacokinetic\/pharmacodynamic predictors of clinical potency for hepatitis C virus nonnucleoside polymerase and protease inhibitors","volume":"56","author":"Reddy","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2014.02.012_b0345","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ajic.2011.10.003","article-title":"Frequency of outbreak investigations in US hospitals: results of a national survey of infection preventionists","volume":"40","author":"Rhinehart","year":"2012","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.antiviral.2014.02.012_b0350","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.bbmt.2012.07.005","article-title":"Norovirus infection in pediatric hematopoietic stem cell transplantation recipients: incidence, risk factors, and outcome","volume":"18","author":"Robles","year":"2012","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.antiviral.2014.02.012_b0355","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.bmc.2010.05.006","article-title":"(E)-2-styrylchromones as potential anti-norovirus agents","volume":"18","author":"Rocha-Pereira","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2014.02.012_b0360","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bbrc.2012.07.034","article-title":"Favipiravir (T-705) inhibits in vitro Norovirus replication","volume":"424","author":"Rocha-Pereira","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2014.02.012_b0365","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.bbrc.2012.10.003","article-title":"Inhibition of Norovirus replication by the nucleoside analogue 2\u2032-C-methylcytidine","volume":"427","author":"Rocha-Pereira","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2014.02.012_b0370","doi-asserted-by":"crossref","first-page":"11798","DOI":"10.1128\/JVI.02064-13","article-title":"The viral polymerase inhibitor 2\u2032-C-methylcytidine inhibits Norwalk virus replication and protects against Norovirus-induced diarrhea and mortality in a mouse model","volume":"87","author":"Rocha-Pereira","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0375","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1086\/605557","article-title":"Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity","volume":"49","author":"Roddie","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.02.012_b0380","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.antiviral.2010.05.002","article-title":"Antiviral strategies to control calicivirus infections","volume":"87","author":"Rohayem","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2014.02.012_b0385","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/TP.0b013e31821c9392","article-title":"Impact of norovirus\/sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea","volume":"92","author":"Roos-Weil","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2014.02.012_b0390","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1365-2036.2006.03128.x","article-title":"Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial","volume":"24","author":"Rossignol","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2014.02.012_b0395","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(06)68852-1","article-title":"Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial","volume":"368","author":"Rossignol","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2014.02.012_b0400","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1399-3046.2011.01500.x","article-title":"Chronic norovirus infection in pediatric hematopoietic stem cell transplant recipients: a cause of prolonged intestinal failure requiring intensive nutritional support","volume":"15","author":"Saif","year":"2011","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.antiviral.2014.02.012_b0405","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3201\/eid1701.P11101","article-title":"Foodborne illness acquired in the United States \u2013 major pathogens","volume":"17","author":"Scallan","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.02.012_b0410","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1086\/653939","article-title":"Chronic norovirus infection after kidney transplantation: molecular evidence for immune-driven viral evolution","volume":"51","author":"Schorn","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"117","key":"10.1016\/j.antiviral.2014.02.012_b0415","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1182\/blood-2010-12-325886","article-title":"Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation","volume":"2","author":"Schwartz","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2014.02.012_b0420","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.1128\/AEM.05806-11","article-title":"Norovirus infectivity in humans and persistence in water","volume":"77","author":"Seitz","year":"2009","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0425","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jinf.2011.08.002","article-title":"Norovirus gastroenteritis successfully treated with nitazoxanide","volume":"63","author":"Siddiq","year":"2011","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2014.02.012_b0430","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1086\/591627","article-title":"High prevalence of prolonged norovirus shedding and illness among hospitalized patients: a model for in vivo molecular evolution","volume":"198","author":"Siebenga","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.02.012_b0435","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/00365520500421694","article-title":"Norovirus outbreak in a pediatric oncology unit","volume":"41","author":"Simon","year":"2006","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0440","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3345\/kjp.2013.56.9.383","article-title":"Acute viral gastroenteritis in children hospitalized in Iksan, Korea during December 2010\u2013June 2011","volume":"56","author":"So","year":"2013","journal-title":"Korean J. Pediatr."},{"key":"10.1016\/j.antiviral.2014.02.012_b0445","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/cid\/cir971","article-title":"Nosocomial transmission of norovirus is mainly caused by symptomatic cases","volume":"54","author":"Sukhrie","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.02.012_b0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399407000348","article-title":"Norovirus\u2013host interaction: implications for disease control and prevention","volume":"9","author":"Tan","year":"2007","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.antiviral.2014.02.012_b0455","doi-asserted-by":"crossref","first-page":"e1000983","DOI":"10.1371\/journal.ppat.1000983","article-title":"Norovirus gastroenteritis, carbohydrate receptors, and animal models","volume":"6","author":"Tan","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2014.02.012_b0465","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.virusres.2013.09.008","article-title":"Structural and inhibitor studies of norovirus 3C-like proteases","volume":"178","author":"Takahashi","year":"2013","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2014.02.012_b0470","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2013.11.016","article-title":"Naphthalene-sulfonate inhibitors of human norovirus RNA-dependent RNA-polymerase","volume":"102","author":"Tarantino","year":"2014","journal-title":"Antiviral Res."},{"issue":"4","key":"10.1016\/j.antiviral.2014.02.012_b0475","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00450-13","article-title":"A mouse model for human norovirus","volume":"4","author":"Taube","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.antiviral.2014.02.012_b0480","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1128\/JVI.03389-12","article-title":"Persistent enteric murine norovirus infection is associated with functionally suboptimal virus-specific CD8 T cell responses","volume":"87","author":"Tomov","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0485","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jmv.21237","article-title":"Norwalk virus: how infectious is it?","volume":"80","author":"Teunis","year":"2008","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0490","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ajic.2012.08.002","article-title":"Clinical characteristics of norovirus-associated deaths: a systematic literature review","volume":"41","author":"Trivedi","year":"2013","journal-title":"Am. J. Infect. Control"},{"key":"10.1016\/j.antiviral.2014.02.012_b0495","doi-asserted-by":"crossref","first-page":"e1003343","DOI":"10.1371\/journal.ppat.1003343","article-title":"Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets","volume":"9","author":"van der Vries","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2014.02.012_b0500","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bpg.2012.09.011","article-title":"The role of resistance in HCV treatment","volume":"26","author":"Vermehren","year":"2012","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.antiviral.2014.02.012_b0505","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2013.01.006","article-title":"RNA binding by human Norovirus 3C-like proteases inhibits protease activity","volume":"438","author":"Viswanathan","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2014.02.012_b0510","doi-asserted-by":"crossref","first-page":"701","DOI":"10.5414\/CPP47701","article-title":"Unexpected serum level of vancomycin after oral administration in a patient with severe colitis and renal insufficiency","volume":"47","author":"Yamazaki","year":"2009","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2014.02.012_b0515","doi-asserted-by":"crossref","first-page":"7705","DOI":"10.1074\/jbc.M709563200","article-title":"Structural insights into mechanisms of catalysis and inhibition in Norwalk virus polymerase","volume":"283","author":"Zamyatkin","year":"2008","journal-title":"JBC"},{"key":"10.1016\/j.antiviral.2014.02.012_b0520","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jmb.2009.04.069","article-title":"Binding of 2\u2032-amino-2\u2032-deoxycytidine-5\u2032-triphosphate to Norovirus polymerase induces rearrangement of the active site","volume":"390","author":"Zamyatkin","year":"2009","journal-title":"J. Mol. Biol."},{"issue":"7","key":"10.1016\/j.antiviral.2014.02.012_b0525","doi-asserted-by":"crossref","first-page":"e68413","DOI":"10.1371\/journal.pone.0068413","article-title":"Linking time-varying symptomatology and intensity of infectiousness to patterns of Norovirus transmission","volume":"8","author":"Zelner","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.antiviral.2014.02.012_b0530","doi-asserted-by":"crossref","first-page":"e69379","DOI":"10.1371\/journal.pone.0069379","article-title":"Inhibition of histo-blood group antigen binding as a novel strategy to block norovirus infections","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.antiviral.2014.02.012_b0535","doi-asserted-by":"crossref","first-page":"e1003592","DOI":"10.1371\/journal.ppat.1003592","article-title":"Identification of immune and viral correlates of norovirus protective immunity through comparative study of intra-cluster norovirus strains","volume":"9","author":"Zhu","year":"2013","journal-title":"PLoS Pathog."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214000552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214000552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T19:49:18Z","timestamp":1565207358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214000552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":106,"alternative-id":["S0166354214000552"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.02.012","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of norovirus infections: Moving antivirals from the bench to the bedside","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}